PENTAMIDINE ISETHIONATE Drug Patent Profile
✉ Email this page to a colleague
When do Pentamidine Isethionate patents expire, and when can generic versions of Pentamidine Isethionate launch?
Pentamidine Isethionate is a drug marketed by Seton Pharms, X-gen Pharms Inc, Avet Lifesciences, Baxter Hlthcare, Hospira, Watson Labs, and Xgen Pharms. and is included in eight NDAs.
The generic ingredient in PENTAMIDINE ISETHIONATE is pentamidine isethionate. There are fourteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the pentamidine isethionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pentamidine Isethionate
A generic version of PENTAMIDINE ISETHIONATE was approved as pentamidine isethionate by SETON PHARMS on September 28th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PENTAMIDINE ISETHIONATE?
- What are the global sales for PENTAMIDINE ISETHIONATE?
- What is Average Wholesale Price for PENTAMIDINE ISETHIONATE?
Summary for PENTAMIDINE ISETHIONATE
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Clinical Trials: | 23 |
| Patent Applications: | 1,629 |
| Drug Prices: | Drug price information for PENTAMIDINE ISETHIONATE |
| DailyMed Link: | PENTAMIDINE ISETHIONATE at DailyMed |
Recent Clinical Trials for PENTAMIDINE ISETHIONATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mayo Clinic | Phase 1 |
| University of Louisville | Phase 1 |
| Gyongyi Szabo | Phase 1 |
Pharmacology for PENTAMIDINE ISETHIONATE
| Drug Class | Antiprotozoal |
Medical Subject Heading (MeSH) Categories for PENTAMIDINE ISETHIONATE
Anatomical Therapeutic Chemical (ATC) Classes for PENTAMIDINE ISETHIONATE
US Patents and Regulatory Information for PENTAMIDINE ISETHIONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seton Pharms | PENTAMIDINE ISETHIONATE | pentamidine isethionate | FOR SOLUTION;INHALATION | 206667-001 | Apr 24, 2019 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 074303-001 | Aug 17, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 073617-001 | Dec 18, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Xgen Pharms | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 206982-001 | Mar 17, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
